The trademark application Stemchymal -lumonistrocel- was filed by Steminent Biotherapeutics Inc., a corporation established under the laws of Taiwan, Republic of China (the "Applicant"). Application under examination.
The application was filed in Dutch (English was selected as the second language).
Goods And Services
The mark was filed in class 44 with following description of goods:
Medical treatment services
Regenerative medicine services
Medical treatment using cultured cells
Medical examination
Cultured cell bank services for medical transplantation
Ursing, medical
Medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Medical screening
Medical consultancy
Pharmacy advice
(Medical) Cosmetic treatment
Medical clinic services
Pathological examination for medical diagnosis and treatment